Hematology TimesFirst randomized evidence for kinase inhibitor use in AMLDecember 11, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA approves drug for HCMDecember 11, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology TimesMore isn’t always better with daunorubicin induction in AMLDecember 10, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesEncapsulating doxorubicin can reduce heart damageDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesCLL drug can fight AML too, study suggestsDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Hematology TimesDisordered methylation compromises CLL treatmentDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesFinding could help docs tailor treatment for myeloid leukemiasDecember 9, 2014Leukemia, Myelodysplasia, TransplantationAMLCML
Oncology PracticeSorafenib boosts event-free survival of adult AMLDecember 8, 2014Leukemia, Myelodysplasia, TransplantationAML
Oncology PracticeYoung adults with ALL have better survival with pediatric regimensDecember 8, 2014Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesMouse model reveals insight into CLL relapseDecember 8, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myelomaDecember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology TimesHealth Canada approves ibrutinib for CLLDecember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesPeople often dismiss cancer symptoms, survey suggestsDecember 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesBreast cancer drug could treat MPNs, AMLDecember 5, 2014CythemiasLeukemia, Myelodysplasia, TransplantationAML
Hematology TimesNICE reconsiders obinutuzumab for CLLDecember 5, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
